4//SEC Filing
Moriarty John B 4
Accession 0001599901-25-000138
CIK 0001599901other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 5:27 PM ET
Size
6.0 KB
Accession
0001599901-25-000138
Insider Transaction Report
Form 4
Moriarty John B
Chief Legal Officer
Transactions
- Sale
Common Stock
2025-08-04$36.21/sh−2,245$81,291→ 47,755 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs on August 1, 2025 and the sale of the resulting shares of common stock on August 4, 2025. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary trade by the Reporting Person. The Reporting Person has executed an instruction letter for the automatic sale of such "sell-to-cover" shares, intended to satisfy the affirmative defense conditions of Rule 10b5-1.
- [F2]This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $35.92 to $36.21. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Avidity Biosciences, Inc.
CIK 0001599901
Entity typeother
Related Parties
1- filerCIK 0001564621
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 5:27 PM ET
- Size
- 6.0 KB